Question · Q4 2025
Edison Lee inquired about the utilization plan for the $111 million raised from the sale of ACM Shanghai shares and sought further comment on the pricing pressure affecting some products in Q4.
Answer
CEO David Wang explained that proceeds from ACM Shanghai's private offering are focused on R&D and manufacturing expansion, including a second building for $3 billion annual output and the Ningdong mini-line. The $111 million from the 1.3% Shanghai share sale will primarily fund global customer engagement, marketing, sales, and establishing a US assembly base to mitigate tariff impacts. CFO Mark McKechnie reiterated that a few semi-critical products faced low margins in Q3 and Q4 due to competitive pressure, and a larger inventory provision in the latter half of 2025 contributed to the margin impact, with expectations for a smaller and more balanced provision in 2026.
Ask follow-up questions
Fintool can predict
ACMR's earnings beat/miss a week before the call